You have 9 free searches left this month | for more free features.

Scleritis

Showing 1 - 25 of 96

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Idiopathic Refractory Scleritis Trial (Infliximab, Cyclophosphamide)

Withdrawn
  • Idiopathic Refractory Scleritis
  • (no location specified)
Jul 18, 2022

Uveitis, Scleritis Trial in Saint Louis (tofacitinib)

Unknown status
  • Uveitis
  • Scleritis
  • Saint Louis, Missouri
    Washington University in Saint Louis
Jan 7, 2021

Human Samples and Data Repository

Completed
  • Uveitis
  • Scleritis
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Mar 18, 2021

    Scleritis Trial run by the NEI (Sirolimus)

    Completed
    • Scleritis
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Jun 4, 2020

    Hereditary Autoinflammatory Diseases, Schnitzler Syndrome, Behcet Syndrome Trial in Worldwide (No intervention is foreseen by

    Recruiting
    • Hereditary Autoinflammatory Diseases
    • +7 more
    • No intervention is foreseen by the protocol.
    • Bethesda, Maryland
    • +99 more
    Jan 6, 2022

    Immune Cell Signatures in Autoimmunity and Dry Eye Syndrome

    Recruiting
    • Autoimmunity
    • Dry Eye Syndrome
    • Cross-sectional study
    • Singapore, Singapore
      Cynthia Boo
    Mar 22, 2022

    Lyon Uveitis Study

    Recruiting
    • Uveitis
    • No specific intervention. Collection of clinical data
    • Lyon, France
      Department of Internal Medicine, Croix-Rousse Hospital, Hospices
    Mar 18, 2022

    Lyon Sarcoid Uveitis Cohort

    Recruiting
    • Sarcoid Uveitis
    • No intervention
    • Lyon, France
      Hospices Civils de Lyon
    Mar 18, 2022

    Scleritis Trial run by the NEI (Gevokizumab)

    Completed
    • Scleritis
    • Gevokizumab
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Jul 3, 2018

    Biosimilars of Rituximab in ANCA-associated Vasculitis Compared

    Recruiting
    • ANCA-associated Vasculitis
    • +2 more
      • Calgary, Alberta, Canada
      • +8 more
      Jan 27, 2023

      AS-OCT Study of Cornea and Tear Film Parameters in SLE Patients

      Completed
      • Systemic Lupus Erythematosus
      • Anterior Segment OCT
      • Minya, Egypt
        Minia university hospital
      Jan 20, 2022

      Hypertension, Heart Failure, Vascular Ischemia Trial in Iowa City (laser speckle flowgraphy)

      Completed
      • Hypertension
      • +15 more
      • laser speckle flowgraphy
      • Iowa City, Iowa
        University of Iowa Department of Ophthalmology
      Sep 5, 2018

      Ocular Manifestations of Inflammatory Bowel Disease

      Completed
      • Inflammatory Bowel Diseases
      • Ophthalmopathy
      • reason for consultation
      • (no location specified)
      Feb 24, 2021

      Cornea and Tear Film Parameters in Juvenile SLE Patients

      Recruiting
      • Juvenile Systemic Lupus Erythematosus
      • Anterior Segment OCT
      • Minya, Egypt
        Minia University Hospital
      Aug 16, 2021

      Crohn's Disease Trial in Worldwide (Entocort)

      Completed
      • Crohn's Disease
      • Aurora, Colorado
      • +23 more
      Jan 4, 2022

      Uveitis, Anterior Uveitis, Intermediate Uveitis Trial in Saint Petersburg (H.P. ACTHAR SUBCUTANEOUS GEL INJECTION)

      Completed
      • Uveitis
      • +5 more
      • H.P. ACTHAR SUBCUTANEOUS GEL INJECTION
      • Saint Petersburg, Florida
        Tampa Bay Uveitis Center
      Jun 29, 2018

      Retinitis Pigmentosa Trial in Worldwide (Implant of Argus II Retinal Prosthesis)

      Completed
      • Retinitis Pigmentosa
      • Implant of Argus II Retinal Prosthesis
      • Los Angeles, California
      • +11 more
      Jan 11, 2022

      Differential Diagnosis of Sjögren's Versus Non-Sjögren's Dry Eye

      Recruiting
      • Keratoconjunctivitis Sicca
      • +3 more
      • Questionnaires
      • +2 more
      • Baltimore, Maryland
        Wilmer Eye Insitute, Johns Hopkins School of Medicine
      Jan 18, 2022

      Glaucoma, Ocular Hypertension Trial in Japan (Xalatan, Xalacom)

      Completed
      • Glaucoma
      • Ocular Hypertension
      • Ichinomiya, Aichi, Japan
      • +53 more
      Aug 16, 2021

      Myelodysplastic Syndrome (MDS) With Refractory Anemia (RA), Severe Aplastic Anemia (SAA) Trial run by the NHLBI (Umbilical Cord

      Completed
      • Myelodysplastic Syndrome (MDS) With Refractory Anemia (RA)
      • Severe Aplastic Anemia (SAA)
      • Umbilical Cord Blood
      • Bethesda, Maryland
        National Institutes of Health Clinical Center, 9000 Rockville Pi
      Dec 16, 2021

      Congenital Hereditary Endothelial Dystrophy of Cornea Trial in Hyderabad (Nepafenac 0.1% Oph Susp, Refresh Tears 0.5% Lubricant

      Recruiting
      • Congenital Hereditary Endothelial Dystrophy of Cornea
      • Nepafenac 0.1% Oph Susp
      • Refresh Tears 0.5% Lubricant Eye Drops
      • Hyderabad, Banjara Hills, India
        L V Prasad Eye Institute
      Apr 8, 2021

      Neovascular Age-Related Macular Degeneration Trial in United States (Drug: GB-102, Aflibercept)

      Completed
      • Neovascular Age-Related Macular Degeneration
      • Gilbert, Arizona
      • +32 more
      Jan 10, 2022

      Scleritis Trial run by the NEI (Infliximab)

      Completed
      • Scleritis
      • Bethesda, Maryland
        National Institutes of Health Clinical Center, 9000 Rockville Pi
      Jun 30, 2017

      Crohn Disease Trial in Worldwide (RHB-104 (fixed-dose combination: 95 mg clarithromycin, 45 mg rifabutin, and 10 mg

      Completed
      • Crohn Disease
      • RHB-104 (fixed-dose combination: 95 mg clarithromycin, 45 mg rifabutin, and 10 mg clofazimine)
      • San Carlos, California
      • +23 more
      Feb 7, 2021

      Leflunomide in Egyptian Active Rheumatoid Arthritis

      Completed
      • Active Rheumatoid Arthritis
        • Cairo, Egypt
          Private clinics
        Jun 14, 2020